Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription


Por: Estevez F, Alarcon M, Babarro A, Gayoso L, de Castro J, Leria-Gelabert M, Melogno-Klinkas M

Publicada: 2 ago 2020 Ahead of Print: 1 jun 2020
Resumen:
Objectives:Multiple reasons for suboptimal treatment of breakthrough cancer pain (BTcP) have been reported in the literature. We aimed to ascertain the perception of physicians on the potential inappropriate use and prescription of rapid-onset opioids (ROOs) for breakthrough cancer pain (BTcP) and the causes thereof. Methods:Observational study based on an online survey addressed to doctors from different specialties (radiation oncology, medical oncology, anesthesia, palliative care and general practitioners) with experience in the management of BTcP in the Spanish public health setting. Results:A total of 114 eligible specialists mainly from radiation oncology (37.7%), medical oncology (24.6%) and pain units (18.4%) participated in the study. Most agreed on important aspects of BTcP management, such as their preference for ROOs or the need for early follow-up after treatment initiation. However, their answers revealed a lack of standardization of BTcP diagnosis. Half of respondents believed that their BTcP patients might misuse ROOs. Physicians polled believed that lack of training in pain management (71.9%) and inadequate BTcP diagnosis and evaluation (66.7%) were the greatest obstacles for prescribing opioids. Specialists also thought that they do not provide the necessary information to patients (51.8%) and caregivers (57.9%) to guarantee the correct use of these drugs. Conclusions:These results are of utmost importance as they highlight the need to increase physicians' awareness of BTcP and its management and the need to improve communication with patients and their caregivers. Our findings also indicate the need for future research on the possible misuse of opioids in BTcP patients and its causes.

Filiaciones:
Estevez F:
 Consorcio Hosp Prov Castellon, Pain Unit, Castellon de La Plana, Spain

Alarcon M:
 Hosp Gen Univ Valencia, Pain Unit, Valencia, Spain

Babarro A:
 Hosp Univ Paz, Palliat Care Unit, Madrid, Spain

Gayoso L:
 Hosp Univ Cent Asturias, Radiat Oncol Dept, Oviedo, Spain

de Castro J:
 Hosp Univ Paz, Med Oncol Dept, Madrid, Spain

Leria-Gelabert M:
 Mylan, Med Dept, Madrid, Spain

Melogno-Klinkas M:
 Mylan, Med Dept, Madrid, Spain
ISSN: 03007995





CURRENT MEDICAL RESEARCH AND OPINION
Editorial
Taylor & Francis, 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 36 Número: 8
Páginas: 1383-1391
WOS Id: 000545143700001
ID de PubMed: 32453602

MÉTRICAS